Dilafor AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Holding
- Established
- 2003-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.dilafor.com
Clinical Trials
10
Active:7
Completed:3
Trial Phases
2 Phases
Phase 1:6
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (66.7%)Phase 2
3 (33.3%)Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 365
- Registration Number
- NCT04000438
- Locations
- 🇫🇮
Naistenklinikka (HUS), Helsinki, Finland
🇫🇮Tampere University Hospital, Tampere, Finland
🇸🇪Kvinnokliniken Universitetssjukhuset Linköping, Linköping, Sweden
Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 361
- Registration Number
- NCT03001193
- Locations
- 🇩🇰
Hvidovre Hospital, Fødeafdelingen, Hvidovre, Denmark
🇫🇮Naistenklinikka (HUS) Naistentaudit ja synnytykset, Helsinki, Finland
🇫🇮Kätilöopiston Sairaala (HUS), Helsinki, Finland
Study to Assess Safety and Efficacy of DF01 in Reducing Prolonged Labor
- First Posted Date
- 2008-07-04
- Last Posted Date
- 2009-05-19
- Lead Sponsor
- Dilafor AB
- Target Recruit Count
- 263
- Registration Number
- NCT00710242
- Locations
- 🇸🇪
Kvinnokliniken Alvsborgs sjukhus Boras, Boras, Sweden
🇸🇪Gavle sjukhus, Gavle, Sweden
🇸🇪Sahlgrenska/Ostra sjukhuset, Goteborg, Sweden
News
No news found